|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01515 CR MEDICAL
Nominal 
4.970 -0.160 (-3.119%) | 2022/12 - Final RMB(K¥) | %Chg (Final to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | ||
| Turnover | 5,620,461 | 26.374% | 4,447,477 | 2,750,650 | 2,115,320 | 2,059,478 | |
| Cost of Sales | (4,649,321) | 32.311% | (3,513,922) | (2,114,143) | (1,353,029) | (1,302,800) | |
| Gross Profit | 971,140 | 4.026% | 933,555 | 636,507 | 762,291 | 756,678 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (145,588) | -59.023% | (355,289) | (23,525) | (1,577) | (65) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 88,068 | 5.402% | 83,554 | 34,968 | 4,646 | 2,147 | |
| Profit / (Loss) before Taxation | 242,413 | -10.375% | 270,475 | 418,185 | 541,299 | 588,943 | |
| Taxation | (83,071) | -- | 155,389 | (97,864) | (140,665) | (149,387) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (20,368) | 156.233% | (7,949) | (10,190) | (9,769) | (8,658) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 138,974 | -66.746% | 417,915 | 310,131 | 390,865 | 430,898 | |
| Net Finance Costs / (Income) | (41,797) | -29.885% | (59,612) | (62,539) | (48,042) | (58,722) | |
| Depreciation & Amortisation | 332,483 | 81.805% | 182,879 | 113,382 | 63,644 | 72,988 | |
| Directors' Emoluments | -- | -- | 13,079 | 18,418 | 23,782 | 15,044 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 11.000 | -- | 33.000 | 25.000 | 31.000 | 34.000 |
| DPS (cts) | 3.344 | -- | 10.238 | 7.400 | 9.000 | 10.200 |
| Dividend Payout Ratio (%) | 30.399% | -- | 31.024% | 29.600% | 29.032% | 30.000% |
| Cash flow per share ($) | -- | -- | 0.566 | 0.513 | 0.292 | 0.264 |
| NBV per share ($) | 4.983 | -- | 4.975 | 4.709 | 4.553 | 4.311 |
| Remarks: | Real time quote last updated: 03/10/2023 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 397,677 |
| %Change | 62.537% |
| EPS / (LPS) | RMB 0.310 |
| NBV Per Share (¥) | RMB 4.596 |